Osmotica Pharmaceutical
Manufacturing · Georgia, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
895 Sawyer Rd, Marietta, Georgia, 30062,...Phone Number
(770) 509-4500Website
www.osmotica.comRevenue
$165.9 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Osmotica Pharmaceutical
Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical and contract development and manufacturing organization headquartered at 895 Sawyer Rd, Marietta, Georgia. with operations in the United States and Hungary, specializing in the development, manufacturing, and commercialization of specialty pharmaceutical products targeting markets with underserved patient populations. Founded through the 2016 combination of Osmotica Holdings Corp Ltd and Vertical/Trigen, the company operates as one of the world's leading osmotic drug delivery companies, leveraging significant research and development resources and proprietary drug delivery technology, including extended and modified release technologies, laser drilling capabilities, and innovative osmotic technology drug delivery systems.Explore more
Osmotica Pharmaceutical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Osmotica Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Osmotica Pharmaceutical launches new products
Earning: See what the market has to say on Osmotica Pharmaceutical recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Osmotica Pharmaceutical
Osmotica Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Osmotica Pharmaceutical had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Osmotica Pharmaceutical has new funding data
Check out if Osmotica Pharmaceutical is spiking on competitors!
Check if Osmotica Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Osmotica Pharmaceutical as Masked Content
Find more new buyers
Compare Similar Companies to Osmotica Pharmaceutical
Compare insights from companies similar to Osmotica Pharmaceutical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Osmotica Pharmaceutical
$165.9M
51-200
Private
$168.9M
2017
Td
Tina deVriesExecutive VP, Research & Development
Company Profile Activity
Activity Insights
Osmotica Pharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Osmotica Pharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Osmotica Pharmaceutical.
Osmotica Pharmaceutical financials insights
Gather financial insights about Osmotica Pharmaceutical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$100M
2022
Other Financing Round
$68.9M
Osmotica Pharmaceutical Tech Stack
A closer look at the technologies used by Osmotica Pharmaceutical
Most Recent Scoops
Open Position
Hiring Plans
Osmotica Pharmaceutical has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Funding
Project
Osmotica Pharmaceutical News & Media
RVL Pharmaceuticals plc (RVLP) CEO Brian Markison on Q1 2022 Results - Earnings Call Transcript
RVL Pharmaceuticals plc (NASDAQ:NASDAQ:RVLP) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Lisa Wilson – Investor Relations Brian Markison – Chief Executive...RVL Pharmaceuticals plc Reports First Quarter 2022 Financial Results; Provides Commercial Update
First quarter 2022 UPNEEQ net product sales of $5.9 million; 90% growth over fourth quarter 2021RVL Pharmaceuticals plc - Ordinary Shares's Earnings: A Preview
RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. read moreUPNEEQ® Wins Best Professional-Treatment Product by Shape Magazine in the 2022 "Shape Healthy Skin Awards"
BRIDGEWATER, N.J., May 9, 2022 /PRNewswire/ -- RVL Pharmaceuticals plc (Nasdaq: RVLP) ("RVL" or the "Company") announced today that its FDA approved ptosis drug Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1% has received another industry award. Upneeq was selected as the...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Osmotica Pharmaceutical
Sign Up For FreeTo access detailed company insights
Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical and contract development and manufacturing organization headquartered at 895 Sawyer Rd, Marietta, Georgia. with operations in the United States and Hungary, specializing in the development, manufacturing, and commercialization of specialty pharmaceutical products targeting markets... Read More
